MEGGA MIX: Food-Derived IgY for Hospital-Based Gut Health Support in Patients Receiving Antibiotics
Target Patient Population
Age ≥65
Receiving systemic antibiotics
Able to take oral nutrition (not NPO)
Moderate/high risk for functional decline, frailty, or infection
Exclusions:
Egg allergy, severe fat malabsorption, or enteral tube feeding unless approved by dietitian
Protocol Overview
MEGGA MIX is a physician-supervised, hospital-administered nutritional intervention designed to support gut microbial balance in patients receiving high-risk antibiotics. It may be considered in clinical evaluation, pilot programs, or research protocols.
Administration Timeline
| Stage | Action |
|---|---|
| Hospital stay | 2 daily 10 g servings mixed with water or milk; administered via meal tray or nursing |
| Discharge | Remaining powder provided for post-discharge continuation under supervision |
| Home use | Patient follows instructions for continued support during recovery period |
Clinical Nutrition Rationale
Protein, vitamins, minerals
Supports muscle, cognition, immune function, and recovery
Targeted IgY antibodies
Designed to support microbial balance in the gut during antibiotic exposure
Digestibility
Senior-friendly, low-lactose, low-glycemic
Integration with Hospital Protocols
- Compatible with all antibiotic regimens, no systemic absorption
- Can be integrated into nutrition services alongside standard enteral nutrition
- Aligns with antimicrobial stewardship goals and preventive care initiatives
Economic Considerations
Illustrative projections (pending clinical validation):
- Potential to reduce infection-related isolation days and associated costs
- Supports hospital quality metrics and HAC avoidance
- Minimal workflow disruption; procurement via standard food service channels
Product Overview
| Item | Name | MEGGA MIX Microbiome Immunonutrition |
|---|---|---|
| Form | Form | Egg-based powder, flavored |
| Serving | Serving | 10 g (~1 egg equivalent) |
| Duration | Duration | 18 days (hospital + post-discharge) |
| IgY Content | IgY Content | 1,500 mg active IgY per serving |
| Storage | Storage | 24 months dry; 2 hours after mixing |
Disclaimer
MEGGA MIX is under clinical investigation and is not FDA-approved for the prevention or treatment of C. difficile infection. Individual outcomes may vary.